Pharma Awards USA 2020

Publication date: 23 december 2020

The project by the pharmaceutical company PTC Therapeutics "Support for Laboratory Testing of Duchenne Muscular Dystrophy", which is being implemented by Aston Health, was included in the list of nominees for Pharma Awards USA 2020. This is the only project from Russia on that list this year.

Pharma Awards USA is one of the most authoritative awards in the healthcare. In 2020, 60 projects from around the world were selected. PTC Therapeutics is among the finalists for the Patient Champion Award: Pharma. More details about the award and finalists can be found here

 

 

Aston Health's Laboratory Diagnostics Department in collaboration with PTC has developed a molecular genetic testing program to research DMD gene mutations and assemble a pool of patients eligible for pathogenetic treatment.

DMD is a genetic disorder associated with impaired protein dystrophin synthesis for which there no effective treatment to date. To learn more about the condition click here